|
MORC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.957900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.887200E-01 |
| Normal-vs-Stage2 |
3.046000E-01 |
| Normal-vs-Stage3 |
4.058500E-02 |
| Normal-vs-Stage4 |
5.012400E-01 |
| Stage1-vs-Stage2 |
2.986600E-01 |
| Stage1-vs-Stage3 |
3.832500E-02 |
| Stage1-vs-Stage4 |
4.797800E-01 |
| Stage2-vs-Stage3 |
5.493400E-01 |
| Stage2-vs-Stage4 |
8.141800E-01 |
| Stage3-vs-Stage4 |
4.428600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.597800E-02 |
| Normal-vs-AfricanAmerican |
5.322600E-01 |
| Normal-vs-Asian |
2.449400E-01 |
| Caucasian-vs-AfricanAmerican |
5.028200E-01 |
| Caucasian-vs-Asian |
9.229000E-01 |
| AfricanAmerican-vs-Asian |
7.188600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.347800E-01 |
| Normal-vs-Female |
2.397200E-03 |
| Male-vs-Female |
7.576800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.742000E-01 |
| Normal-vs-Extreme_Weight |
7.558400E-01 |
| Normal-vs-Obese |
1.922360E-02 |
| Normal-vs-Extreme_Obese |
6.368200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.264800E-01 |
| Normal_Weight-vs-Obese |
5.973700E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.151000E-01 |
| Extreme_Weight-vs-Obese |
4.557600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.795200E-01 |
| Obese-vs-Extreme_Obese |
3.947700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.258220E-03 |
| Normal-vs-Age(41-60Yrs) |
8.317400E-03 |
| Normal-vs-Age(61-80Yrs) |
8.748200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.408800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.245100E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.97470000000189E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.119540E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.954300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.040290E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.825240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.522300E-02 |
| Normal-VS-Type2 PRCC |
2.924800E-01 |
| Normal-VS-KIRP CIMP |
1.189690E-02 |
| Normal-VS-Unclassified PRCC |
2.786000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.644400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.972000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.088600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.89651999999985E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
9.413900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.291500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.536000E-01 |
| Normal-vs-N1 |
3.838200E-02 |
| Normal-vs-N2 |
1.128760E-01 |
| N0-vs-N1 |
6.070100E-02 |
| N0-vs-N2 |
3.661300E-03 |
| N1-vs-N2 |
4.760000E-01 |
|
|
